ClinicalTrials.gg
RecruitingNCT07771296Updated Oct 13, 2026

Machine Learning for Evaluating and Diagnosing Temporomandibular Disorders

An interventional study of Low-Level Laser Acupuncture and Proprioceptive Training in Temporomandibular Disorders (TMD), TMJ Disorder and TMJ Pain, sponsored by En Chu Kong Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by En Chu Kong Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Oct 13, 2026Now RecruitingFirst site in Taiwan+4 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This study aims to improve clinical efficiency and effectiveness in treating Temporomandibular Disorders (TMD). The researchers will integrate machine learning technology with clinical examination data, CBCT, and MRI to identify the core underlying issues of each patient. Based on this precise, AI-assisted diagnosis, the study will implement a tailored treatment framework. The final goal is to develop predictive algorithms that can determine MRI necessity while ensuring that clinical interventions are highly targeted, efficient, and successful.

Read the detailed description

This study integrates machine learning with a clinical trial framework to optimize the evaluation and management of Temporomandibular Disorders (TMD). A total of 180 eligible participants are expected to be enrolled in the study. To ensure a homogenous sample, strict screening will be conducted using standardized psychometric scales; patients with significant psychosocial confounders (defined as GAD-7 ≥10, PHQ-9 ≥15, PHQ-15 ≥10, or PSQI >5) or comorbidities such as fibromyalgia, rheumatic autoimmune diseases, and trauma history will be excluded. Prior to treatment, baseline clinical examination, cone beam computed tomography (CBCT), and magnetic resonance imaging (MRI) data will be collected. All clinical data and longitudinal pre- and post-treatment MRI findings will be utilized to train advanced multi-modal diagnostic models; based on this foundational intelligence, predictive algorithms will then be developed to determine the necessity of an MRI scan using only clinical data and CBCT images. The enrolled participants will be divided by active maximum mouth opening into two subgroups (≤30 mm and >30 mm) and randomly assigned to three treatment arms: (1) Proprioceptive Training + Sham + LLLT (2 weeks of sham laser followed by 2 weeks of active laser acupuncture); (2) Proprioceptive Training + LLLT + LLLT (4 weeks of active laser acupuncture); and (3) Waiting List Control (receiving standard conservative care only).Proprioceptive training includes gentle teeth tapping, tongue-to-palate contact, and neutral head-neck posture exercises, performed three times daily. LLLT targets the Xiaguan (ST7), Yifeng (SJ17), and bilateral Fengchi (GB20) points once weekly. Assessments will be conducted biweekly during treatment, with final evaluation at 4 weeks and follow-ups at 1, 3, 6, 12, and 24 months post-treatment. Post-treatment MRI will be performed at the 4-week endpoint to evaluate objective intra-articular and perimuscular soft-tissue changes, correlating with improvements in pain resolution efficiency and mandibular range of motion recovery.

02

Conditions studied

  • Temporomandibular Disorders (TMD)
  • TMJ Disorder
  • TMJ Pain

Keywords

  • Machine Learning
  • Cone-Beam Computed Tomography
  • CBCT
  • Magnetic Resonance Imaging
  • MRI
  • Proprioceptive Training
  • low level laser
  • Laser Acupuncture
03

In context

Temporomandibular Joint Disorders

591 studies on the registry are indexed under Temporomandibular Joint Disorders; 149 are open to participants now.

This study's planned enrollment of 180 is above the median of 45 across 415 interventional studies indexed under Temporomandibular Joint Disorders.

Browse Temporomandibular Joint Disorders studies →

Lead sponsor

En Chu Kong Hospital is the lead sponsor of 10 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with temporomandibular disorders (TMDs) screened by the Department of Dentistry, Division of Oral and Maxillofacial Surgery at En Chu Kong Hospital, who have failed to respond to analgesic treatment for at least one week.
  • Patients clinically examined and identified as having pain predominantly originating from muscles associated with mandibular movement.
  • Patients aged between 18 and 70 years (inclusive) with full legal capacity.
  • Patients who are willing to participate in the study and provide written .

Exclusion criteria

Exclusion Criteria:

  • Patients meeting any of the following clinical scale thresholds: Generalized Anxiety Disorder-7 (GAD-7)≥ 10, Patient Health Questionnaire-9 (PHQ-9) ≥ 15, Patient Health Questionnaire-15 (PHQ-15) ≥ 10, or Pittsburgh Sleep Quality Index (PSQI) > 5.
  • Patients with tumors of the temporomandibular joint (TMJ) or head and neck region.
  • Patients with acute or chronic infections.
  • Patients with a history of neuropathy or stroke.
  • Patients with a history of head and neck trauma.
  • Patients diagnosed with fibromyalgia.
  • Patients diagnosed with or rheumatic diseases.
  • Patients diagnosed with irritable bowel syndrome (IBS).
  • Patients with claustrophobia (unable to undergo MRI examination).
  • Women who are pregnant or lactating, or parents currently in the infant care/nursing period.
  • Patients who have received invasive treatment for temporomandibular joint disorders within the past 3 months.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Proprioceptive Training + Sham + LLLT

    Participants in this group will receive proprioceptive training combined with low-level laser acupuncture. For the first 2 weeks, sham laser acupuncture (identical visual and auditory cues with no energy output) will be administered, followed by 2 weeks of active laser acupuncture. Proprioceptive training will be performed three times daily throughout the 4-week period.

    Device: Low-Level Laser Acupuncture · Behavioral: Proprioceptive Training

  • Experimental
    Proprioceptive Training + LLLT + LLLT

    Participants in this group will receive proprioceptive training combined with 4 weeks of active low-level laser acupuncture. Proprioceptive training will be performed three times daily, and active laser acupuncture will be administered once weekly for the entire 4-week period.

    Device: Low-Level Laser Acupuncture · Behavioral: Proprioceptive Training

  • Active comparator
    Waiting List Control

    Participants assigned to this group will serve as a waiting list control and will receive standard conservative care, specifically utilizing a stabilization splint, during the 4-week trial period. They will not receive the experimental proprioceptive training or laser acupuncture protocols during this phase.

    Device: Stabilization Splint Treatment

Interventions

  • DeviceLow-Level Laser Acupuncture

    Laser acupuncture targets the Xiaguan (ST7), Yifeng (SJ17), and bilateral Fengchi (GB20) points once weekly. For the LLLT+LLLT group, active laser is given for 4 weeks. For the Sham+LLLT group, sham laser is given for the first 2 weeks followed by 2 weeks of active laser.

    Also known as: Low-Level Laser, Laser Acupuncture

  • BehavioralProprioceptive Training

    Includes gentle teeth tapping, tongue-to-palate contact, and neutral head-neck posture exercises, performed three times daily for 4 weeks.

    Also known as: Motor Control Training, Cranio-Cervico-Mandibular Malalignment / Dysfunction Training, Sensorimotor Training, Trigemino-Cervical System Rehabilitation

  • DeviceStabilization Splint Treatment

    Standard conservative clinical care utilizing a hard acrylic flat-plane stabilization splint (centric stabilization splint) for TMD management. The splint is customized to provide even, bilateral occlusal contact in the musculoskeletal stable position during the 4-week trial period.

    Also known as: occlusal splint

06

What researchers measure

Primary outcomes

  1. Tenderness of Masticatory Muscles and Periarticular Temporomandibular Joint Pain

    Evaluated using the Numeric Rating Scale (NRS) 0-10, to measure pain intensity upon palpation of the masticatory muscles and the periarticular structures of the temporomandibular joint.

    Time frame: Baseline, 2 weeks, 4 weeks (endpoint), and long-term follow-ups at 1, 3, 6, 12, and 24 months.

  2. Pain-Free Mandibular Active Range of Motion

    Measured as the maximum active mouth opening (maximum unassisted pain-free opening) in millimeters using a calibrated ruler.

    Time frame: Baseline, 2 weeks, 4 weeks (endpoint), and long-term follow-ups at 1, 3, 6, 12, and 24 months.

  3. Jaw Functional Limitation Scale - 20 (JFLS-20)

    The Jaw Functional Limitation Scale-20 (JFLS-20) is a 20-item patient-reported questionnaire assessing jaw functional limitation during the previous month. Each item is rated from 0 (no limitation) to 10 (severe limitation). Domain scores are calculated as the mean of completed items for mastication (items 1-6), vertical jaw mobility (items 7-10), and verbal and non-verbal communication (items 11-20). The overall JFLS-20 score is the mean of the three domain scores. Scores range from 0 to 10; higher scores indicate greater jaw functional limitation and a worse outcome. A domain score is calculated when no more than 2 mastication items, 1 mobility item, or 2 communication items are missing.

    Time frame: Baseline, 4 weeks (endpoint), and long-term follow-ups at 1, 3, 6, 12, and 24 months.

Secondary outcomes

  1. Cervical active range of motion (AROM) limitation

    Cervical AROM of flexion, extension, left/right rotation, and left/right lateral flexion is measured using a plastic universal goniometer in degrees from 0-80/40/45 etc. For reporting purposes, each movement is categorized as "normal", "limited", or "no movement", based on predefined cutoffs (e.g., rotation ≥80° = normal; 40-79° = limited; \<40° = no movement). The outcome is the proportion of participants with limited cervical AROM at each time point.

    Time frame: Baseline, 2 weeks, 4 weeks (endpoint), and long-term follow-ups at 1, 3, 6, 12, and 24 months.

  2. MRI T2-Weighted Soft Tissue Assessment

    T2-weighted MRI scans were compared with T1-weighted images to identify joint effusion, disc displacement, perimuscular/intramuscular edema, and muscle hemorrhage.

    Time frame: Baseline (pre-treatment) and 4 weeks (post-treatment endpoint).

Other outcomes

  1. Incidence, Severity, and Frequency of Treatment-Emergent Adverse Events Through 4 Weeks

    The occurrence, type, severity, and frequency of adverse events and treatment-related discomfort associated with proprioceptive training, laser acupuncture, or stabilization splint therapy will be recorded. The number of participants experiencing at least one adverse event and the number of adverse events will be summarized by treatment group. Adverse events will be assessed at 2 weeks and 4 weeks, including the 4-week endpoint.

    Time frame: 2 weeks and 4 weeks (endpoint)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect patient privacy and comply with the institutional review board (IRB) regulations

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Not yet recruiting→Recruiting
changed Oct 13, 2026
Sites
1 site added — first site in Taiwan
Show site
  • En Chu Kong Hospital · New Taipei City, Taiwan
Oct 13, 2026
Start date
Oct 5, 2026→Oct 9, 2026 (actual)
Oct 13, 2026
Primary completion
Jun 25, 2027→Jul 25, 2027
Oct 13, 2026
Contact
Study contact changed: •••3456→•••5102; added e•••@gmail.com · •••3456. See the current contact
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Taiwan
    Show site
    • En Chu Kong Hospital · New Taipei City, Taiwan
    Start date Oct 5, 2026→Oct 9, 2026 (now actual)
    Primary completion Jun 25, 2027→Jul 25, 2027
    Contact Study contact changed: •••3456→•••5102; added e•••@gmail.com · •••3456. See the current contact
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07771296
Lead sponsor
En Chu Kong Hospital
Responsible party
Ting-Yu Huang, D.D.S. (Attending Physician, Department of Oral and Maxillofacial Surgery, En Chu Kong Hospital) — Principal investigator
First posted
Aug 18, 2026
Start date
Oct 9, 2026
Primary completion
Jul 25, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Oct 13, 2026

Study contacts

Ting-Yu Huang, D.D.S.
Contact
tingyuh3012@gmail.com
+886-933-605-102
Mei-Ching Chen, RN
Contact
eckh12345@gmail.com
+886-2-2672-3456 ext. 3601
Ching-Po Lin, PhD
study director · Institute of Neuroscience, Brain Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan. Department of Education and Research, Taipei City Hospital, Taipei, Taiwan.
Ching-Mao Chang, MD, PhD
study director · Center for Traditional Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. Institute of Traditional Medicine, and Schools of Chinese Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion